8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Veristat is pleased to attend DPHARM 2026, where clinical operations leaders, innovators, and patient voices come together to explore how clinical trials can be faster, more efficient, and easier for patients and sites to navigate.
This year’s conversations span AI and automation, modern trial design and execution, clinical data management, patient access, and new approaches to reducing operational burden. We’re looking forward to connecting with clinical development leaders to discuss how new ideas can translate into meaningful improvements in trial execution.
Meet with Us
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
AJ Mills, EVP, Global Commercial
Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy
Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.
Meet with us at the DPHARM 2026 Conference by filling out the form below.
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...